Login
Navigate Fool.com
Will KERX beat
the market?
Community Rating: 1 Star: Ominous

8.03 0.00 (0.00%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $7.99
Previous Close $8.03
Daily Range $7.96 - $8.09
52-Week Range $1.55 - $9.98
Market Cap $656.2M
P/E Ratio -30.88
Dividend (Yield) $0.00 (0.0%)
Volume 1,037,370
Average Daily Volume 2,252,481
Current FY EPS -$0.35

How do you think KERX
will perform against the market?

Top KERX Bull/Bear Pitches

 

zzlangerhans (< 20)
Submitted September 6, 2011

Keryx is another biotech which has struggled recently despite an absence of negative developments specific to the company. The company has already reported positive phase III efficacy data for kidney … More

2 Replies Reply Report this Post
 

supez2004 (< 20)
Submitted March 3, 2008

Phase 3 for sulodexide unlikely to impress ...

1 Replies Reply Report this Post

News & Commentary Rss Feed

Biotech Investing for Beginners

3 pointers to help make biotech investing for beginners a little less intimidating.

Biotech Companies: The FDA Doesn't Care About Your Phase 3 Trials

Results? Yes. Starting them? Not so much.

Is Keryx Biopharmaceuticals Burning Too Much Cash?

What is Keryx's burn rate, and how much cash does it have on hand?

3 Key Takeaways From Keryx's Earnings Report

What should investors focus on after this biotech's Q1 report?

These Cutting-Edge Science Stocks Are Soaring

Along with risk comes the potential for doubling and tripling.

3 Speculative Biotech Stocks to Buy Now

These stocks are speculative, but the returns could be spectacular. 3 up-and-coming biotechs to look at buying now.

3 Speculative Biotech Companies Primed to Pop

No products. No earnings. But these 3 speculative biotech companies are ready to take off. No kidding.

A Pair of Stocks With an Amazing Quarter

These stocks soared over the last three months, but are they about to make a return trip to Earth?

Here's What This $3 Billion Market Wizard Has Been Buying

It can pay off to keep an eye on the big investors out there.

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Investors with Losses on Their Investment in Keryx Biop

See More KERX News...

Sector

Healthcare

Industry

Drugs

Keryx Biopharmaceuticals (KERX) Description

A biopharmaceutical company focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer. Website: http://www.keryx.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks